Profilo
Leah Makley was the founder of Viewpoint Therapeutics, Inc., founded in 2014, and held the title of Chief Executive Officer.
Dr. Makley currently holds the positions of Chief Operations Officer at MBC Biolabs and Chief Operating Officer at Deciduous Therapeutics, Inc. since 2022.
Dr. Makley completed an undergraduate degree at the University of Dayton in 2009 and a doctorate at the University of Michigan in 2014.
Posizioni attive di Leah Makley
| Società | Posizione | Inizio |
|---|---|---|
Deciduous Therapeutics, Inc.
Deciduous Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel medicines for immune mechanism | Direttore operativo | 01/02/2022 |
MBC Biolabs
MBC Biolabs Miscellaneous Commercial ServicesCommercial Services Provides life science research and development services | Direttore operativo | - |
Precedenti posizioni note di Leah Makley
| Società | Posizione | Fine |
|---|---|---|
Viewpoint Therapeutics, Inc.
Viewpoint Therapeutics, Inc. BiotechnologyHealth Technology Develops non-surgical treatments for eye diseases | Amministratore Delegato | 01/02/2022 |
Formazione di Leah Makley
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
University of Dayton
University of Dayton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Viewpoint Therapeutics, Inc.
Viewpoint Therapeutics, Inc. BiotechnologyHealth Technology Develops non-surgical treatments for eye diseases | Health Technology |
MBC Biolabs
MBC Biolabs Miscellaneous Commercial ServicesCommercial Services Provides life science research and development services | Commercial Services |
Deciduous Therapeutics, Inc.
Deciduous Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel medicines for immune mechanism | Health Technology |
















